Consolidated Statements of Comprehensive Loss - USD ($)	12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenues
Total revenues	$ 0	$ 0
Operating expenses:
Research and development	2,009,323	2,296,668
General and administrative	2,769,161	2,180,056
Total operating expenses	4,778,484	4,476,724
Loss from operations	(4,778,484)	(4,476,724)
Interest income	3,926	23,927
Loss before income tax benefit	(4,774,558)	(4,452,797)
Provision for income tax benefit	614,362	0
Net loss	(4,160,196)	(4,452,797)
Other comprehensive income/ (loss)
Foreign currency translation adjustment, net of tax	2,896	(299,263)
Comprehensive loss	$ (4,157,300)	$ (4,752,060)
Net loss per share, basic and diluted	$ (0.20)	$ (0.25)
Weighted average number of common shares outstanding	20,806,307	18,090,384